MYO7B p.Glu1649=
c.4947G>A · rs13025791 · VCV3056512
Benign
No assertion criteria
Classification
Benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Common
common (popmax 31.4%, sas) — too common for a highly-penetrant pathogenic allele
Conditions
1
MYO7B-related disorder
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -0.006 | GERP -3.5, phastCons 0.35 |
| Overall | ||
| CADD | 2.03 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
31.4%
South Asian · 28,339/90,250 alleles
Filtering AF
31.1%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 31%
Overall
19.2%
307,940/1,599,750 alleles · common
exomes 283,693/1,447,474 · genomes 24,247/152,276 · joint denominator
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 31.4% | 3 |
| Finnishnot grpmax-eligible | 22.1% | 5 |
| European (non-Finnish) | 19.7% | 5 |
| Middle Eastern | 19.1% | 5 |
| Remaining individualsnot grpmax-eligible | 18.6% | 5 |
| Ashkenazi Jewishnot grpmax-eligible | 15.2% | 7 |
| East Asian | 13.4% | 7 |
| Admixed American | 12% | 8 |
| African / African-American | 6.52% | 15 |
| Amishnot grpmax-eligible | 3.07% | 33 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MYO7B
- Protein
- p.Glu1649=
- Coding
- c.4947G>A
- MANE Select
- NM_001393586
- dbSNP
- rs13025791
- Type
- single nucleotide variant
- Location
- chr2:127631215 (GRCh38)
- Gene constraint
- LOEUF 0.956 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 78.34 · 3 PDB
- Residue 1649
- the myth4 2 domain; the 'mediates interaction with cdhr2, cdhr5 and ush1c' region
Disease context
MYO7B-related disorder
Similar variants
- MYO7B p.Ala397Ser Uncertain significance ⚠ same condition
- MYO7B c.1081-10G>T Benign same condition
- MYO7B c.1691-7T>C Benign same condition
- MYO7B c.2339+4C>T Benign same condition
- MYO7B c.4333+8C>A Likely benign same condition
- MYO7B c.5714-7C>T Benign same condition
- MYO7B c.5821-8T>C Benign same condition
- MYO7B c.6123+9T>C Benign same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7b-p-glu1649 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown